GEHC gehealthcare.com: Forward P/S Multiple

Graphic logo of GE Healthcare Corp (GEHC)

GE HealthCare is expanding its influence through targeted acquisitions of AI developers to modernize its software. The forward P/S change on GURU.Markets captures the current valuation dynamics, where 1.50 serves as the current parameter value. Growth potential is based on the integration of neural networks into diagnostics and stable service for a massive installed base of equipment worldwide.

gehealthcare.com - GEHC Market Cap to Expected Sales Ratio (period 04/28/2023 - 11/13/2026)

Metric breakdowns and analytics for GE HealthCare Inc. (GEHC)

- current price and projected stock value:
Stock Price GE HealthCare Technologies|GEHC - Average Forecast Price
- company stock capitalization data:
Market Capitalization GE HealthCare Inc.|GEHC - Business Value
- issuer book value statistics:
Book Value per Share GE HealthCare|GEHC - Book Valuation of Business|Market Capitalization to Book Value Ratio gehealthcare.com|GEHC - Cumulative Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital GE HealthCare|GEHC - Long-Term Debt to Capital|Short-Term Debt to Equity GE HealthCare|GEHC - Company Debts|Debt to Book Value GE HealthCare Inc.|GEHC - Company Long-Term Loans and Borrowings|Company Short-Term Debts GE HealthCare|Quick Liquidity gehealthcare.com
- financial results and valuation multiples details:
GEHC - Annual Net Income|Future Profit GE HealthCare|GEHC - P/E Multiple|Forward P/E Multiple GE Healthcare Corp|GEHC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GE HealthCare Inc.|GEHC - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months GE HealthCare|GEHC - Net earnings per share for the last 12 months|Quarterly EPS earnings growth gehealthcare.com|GEHC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year GE HealthCare
- sales volume and revenue indicators:
GEHC - Company Sales Volume|Company Future Sales Volume GE HealthCare Technologies|GEHC - Market Cap to Sales Volume|Forward P/S Multiple GE HealthCare Inc.
Summary company analytics:GE HealthCare Technologies (GEHC)
Product sample of GE HealthCare

Investors struggle to distinguish market noise from an asset's intrinsic value when assessing long-term prospects. The forward P/S ratio compares current market capitalization with projected revenue for the following year, making it possible to identify whether a business is overbought or undervalued. For GE HealthCare (GEHC), the dynamics of this metric are critical, as they reflect the valuation's sensitivity to cost inflation and the risks of reduced government procurement of medical technology.

Key competitors

Forward P/S Multiple ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Market Cap to Future Revenue Ratio|Mettler-Toledo International Inc. - Forward P/S Multiple|WAT (Waters Technologies) - Market Cap to Projected Revenue|TECH: Forward P/S Multiple|BRKR - Market Cap to Expected Sales Ratio|AZTA (Azenta) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Varex Imaging Corp (VREX)|Forward P/S Multiple SMLR|Forward P/S Multiple Butterfly Corp (BFLY)|Price-to-Projected Revenue Ratio Mesa Laboratories, Inc. MLAB|quantum-si.com - Price-to-Projected Revenue Ratio|NNOX: Forward Price-to-Revenue Multiple|Forward Price to Sales QTRX (Quanterix Corp.)|MASS: Forward P/S Multiple|Market Cap to Future Revenue Ratio CapsoVision (CV)|Price-to-Projected Revenue Ratio MaxCyte, Inc.|RPID - Projected Price to Revenue|Forward Price-to-Revenue Multiple SEER (Seer)|Forward P/S Multiple Hyperfine Inc (HYPR)|Forward P/S Multiple FONR (FONAR Corp)|Market Cap to Expected Sales Ratio Daxor Corp (DXR)|MDAI - Price-to-Projected Revenue Ratio|Future Price to Revenue VIVS|Aclarion, Inc. (ACON) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Talis Biomedical Corp TLIS|Price-to-Projected Revenue Ratio T2 Biosystems, Inc. (TTOO)